Selective serotonin reuptake inhibitor discontinuation syndrome: Understanding, recognition, and management for psychologists

Rafael A. Rivas-Vazquez, Mark A. Blais, Sheri L. Johnson, Gustavo J. Rey

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Psychologists increasingly provide psychotherapeutic services to patients receiving concomitant pharmacotherapy. Ongoing experience with the relatively new selective serotonin reuptake inhibitors and other atypical antidepressants has revealed a discontinuation syndrome that emerges following abrupt or tapered withdrawal from these agents. The syndrome has both somatic and psychological characteristics, which tend to be mild and transient but can also be more distressing and become temporarily debilitating. Psychologists need to be aware of the potential for these events, as they are in an optimal position to collaborate with physicians and other prescribing clinicians to prevent or manage this syndrome.

Original languageEnglish (US)
Pages (from-to)464-469
Number of pages6
JournalProfessional Psychology: Research and Practice
Volume30
Issue number5
DOIs
StatePublished - Oct 1999
Externally publishedYes

ASJC Scopus subject areas

  • Psychology(all)

Fingerprint Dive into the research topics of 'Selective serotonin reuptake inhibitor discontinuation syndrome: Understanding, recognition, and management for psychologists'. Together they form a unique fingerprint.

  • Cite this